Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026)
Bausch Health Companies (BHC) reported Deferred Taxes of $30.0 million for Q1 2026, up 433.33% on a YoY basis from $5.6 million in Q1 2025, and down 80.65% sequentially from $155.0 million in Q4 2025.
Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Deferred Taxes data on file, last reported at $30.0 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 433.33% year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (up 4.39% YoY), and the FY2025 full-year result was $80.0 million, up 21.21% from the prior year.
- Deferred Taxes fell to $30.0 million in Q1 2026, from $155.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $170.0 million in Q4 2024 to a low of -$96.0 million in Q3 2022.
- A 5-year average of $3.2 million and a median of -$12.5 million in 2022 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes tumbled 700.0% in 2025 and soared 433.33% in 2026, its largest moves.
- Tracing BHC's Deferred Taxes over 5 years: stood at $19.0 million in 2022, then surged by 342.11% to $84.0 million in 2023, then surged by 102.38% to $170.0 million in 2024, then slipped by 8.82% to $155.0 million in 2025, then tumbled by 80.65% to $30.0 million in 2026.
- Business Quant data shows BHC's Deferred Taxes at $30.0 million in Q1 2026, $155.0 million in Q4 2025, and -$24.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 30.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 155.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | -9.00 Mn |
| Dec 31, 2024 | 170.00 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -44.00 Mn |
| Mar 31, 2024 | -57.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -30.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | -96.00 Mn |
| Jun 30, 2022 | -16.00 Mn |
| Mar 31, 2022 | -83.00 Mn |
| Dec 31, 2021 | -88.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -106.00 Mn |
| Mar 31, 2021 | -14.00 Mn |